EA200200033A1 - METHOD OF TREATING VIRAL HEPATITIS - Google Patents
METHOD OF TREATING VIRAL HEPATITISInfo
- Publication number
- EA200200033A1 EA200200033A1 EA200200033A EA200200033A EA200200033A1 EA 200200033 A1 EA200200033 A1 EA 200200033A1 EA 200200033 A EA200200033 A EA 200200033A EA 200200033 A EA200200033 A EA 200200033A EA 200200033 A1 EA200200033 A1 EA 200200033A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- energy
- reflexotherapy
- hepatobiliary
- organs
- viral hepatitis
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Изобретение относится к медицине, точнее к энергорефлексотерапии и может быть использовано для лечения заболеваний, связанных с вирусными поражениями гепатобилиарной системы и сопряженных органов. Способ заключается в воздействии на значимые БАТ и/или зоны энергорефлексотерапии, отвечающие за нормализацию энергетического состояния гепатобилиарной системы, и/или иммунной системы, и/или нервной системы и сопряженных с ними органов, при этом в качестве сопряженных органов берут поджелудочную железу, тонкий и толстый кишечник, мочевыделительную систему, половые органы, элементы опорно-двигательного аппарата, эндокринные железы, а топологию воздействия связывают с периодами лунного месяца, полнолуния и новолуния, а также временем суток. Учитывается энерготип пациента.The invention relates to medicine, more specifically to energy reflexotherapy and can be used for the treatment of diseases associated with viral lesions of the hepatobiliary system and related organs. The method consists in influencing the significant BAT and / or energy reflexotherapy zones responsible for the normalization of the energy state of the hepatobiliary system and / or the immune system and / or the nervous system and organs associated with them, while the pancreas, the thin and the large intestine, urinary system, genitals, elements of the musculoskeletal system, endocrine glands, and the topology of the impact is associated with periods of the lunar month, full moon and new moon, as well as su current. The patient's energy type is taken into account.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA200200033A EA005044B1 (en) | 2001-10-08 | 2001-10-08 | Method for treating viral hepatitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA200200033A EA005044B1 (en) | 2001-10-08 | 2001-10-08 | Method for treating viral hepatitis |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200200033A1 true EA200200033A1 (en) | 2003-04-24 |
EA005044B1 EA005044B1 (en) | 2004-10-28 |
Family
ID=34072395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200200033A EA005044B1 (en) | 2001-10-08 | 2001-10-08 | Method for treating viral hepatitis |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA005044B1 (en) |
-
2001
- 2001-10-08 EA EA200200033A patent/EA005044B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA005044B1 (en) | 2004-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69733132D1 (en) | USE OF ANTIOXIDANTS FOR THE TREATMENT OF CHOLESTATIVE LIVER DISEASES | |
DK0880350T3 (en) | Treatment of disseminated sclerosis | |
SG146666A1 (en) | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders | |
NO971355L (en) | Photodynamic Therapy in Selective Cell Inactivation in Blood and Treatment of Immune Dysfunction Diseases | |
NZ597965A (en) | Methods of preparing and using stem cell compositions and kits comprising the same | |
ATE266417T1 (en) | MEDICATIONS FOR PREVENTING OR TREATING VASCULAR HEMORRHAGIA | |
IL132798A0 (en) | Monoesters of probucol for the treatment of cardiovascular and inflammatory disease | |
DK1112084T4 (en) | Combination treatments of B-cell lymphomas comprising administration of anti-CD20 antibodies | |
ATE232396T1 (en) | OXIDATED THYMOSINE BETA 4 | |
HK1071687A1 (en) | Pharmaceutical preparation and method of treatmentof human malignancies with arginine deprivation | |
ATE258796T1 (en) | USE OF VITAMIN D4 DERIVATIVES TO TREAT SKIN DISEASES | |
ATE247709T1 (en) | 3'UTR OF THE HUMAN PROHIBITIN GENE | |
ATE453402T1 (en) | USE OF SERP-1 IN COMBINATION WITH AN IMMUNOSUPPRESSOR TO TREAT ARTHRITIS | |
DE69829202D1 (en) | USE OF MIRTAZAPINE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF SLEEP APNOES | |
PT1237562E (en) | PROCESS OF PREPARATION OF MYCANYAN EXTRACTS CONTAINING MICANOLIDE AND DIHYDROMICANOLID AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES | |
TR200200278T2 (en) | Calcilitic compositions | |
MXPA00010254A (en) | The treatment of sexual dysfunction in certain patient groups. | |
EA200200033A1 (en) | METHOD OF TREATING VIRAL HEPATITIS | |
DK1251850T3 (en) | Use of a combination preparation in cancer treatment | |
DE69132682D1 (en) | CELL GROWTH INHIBITORS | |
HUP9904669A3 (en) | Therapeutic applications of t-bam(cd40l)technology to treat diseases involving smooth muscle cells | |
ATE306278T1 (en) | TREATING BONE DISEASES WITH ADRENOMEDULLIN | |
EP0668771A4 (en) | Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs. | |
DK0859630T3 (en) | Combination of thermozolomide and alpha IFN for the treatment of advanced cancer | |
EA200200456A1 (en) | METHOD OF TREATING DISEASES ASSOCIATED WITH ENDOCRINE SYSTEM DISORDERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM BY KZ KG MD TJ TM |
|
PC4A | Registration of transfer of a eurasian patent by assignment | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AZ |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |